Supercharge Your Innovation With Domain-Expert AI Agents!

Application of anti-NINJ1 antibody in preparation of medicine for treating gout and medicine preparation

A technology of pharmaceutical preparations and antibodies, applied in the direction of antibody medical components, antibodies, drug combinations, etc., can solve the problem of no NINJ1 research, and achieve the effect of relieving gout attacks, improving joint inflammation performance, and improving the incidence of gout.

Pending Publication Date: 2022-02-08
ANHUI PROVINCIAL HOSPITAL
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

There are currently no therapeutic targets that directly target this intense inflammatory response, and there are no studies on NINJ1 and gout

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of anti-NINJ1 antibody in preparation of medicine for treating gout and medicine preparation
  • Application of anti-NINJ1 antibody in preparation of medicine for treating gout and medicine preparation
  • Application of anti-NINJ1 antibody in preparation of medicine for treating gout and medicine preparation

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0019] In order to make the object, technical solution and advantages of the present invention clearer, the present invention will be further described in detail below in conjunction with the accompanying drawings and embodiments. It should be understood that the specific embodiments described here are only used to explain the present invention, not to limit the present invention.

[0020] Based on the embodiments of the present invention, all other embodiments obtained by persons of ordinary skill in the art without making creative efforts belong to the protection scope of the present invention.

[0021] Urate, 10 mg / mL, was purchased from Sigma-Aldrich.

[0022] Purified mouse anti-Ninjurin (anti-NINJ1) neutralizing antibody was purchased from BD Biosciences, cat#610777, 250 μg / mL.

[0023] The experimental methods described in the following examples are conventional methods unless otherwise specified; the reagents and materials can be purchased in the market unless otherwi...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides an application of an anti-NINJ1 antibody in preparation of a medicine for treating gout and a medicine preparation, belongs to the technical field of biological medicine and molecular targets, and researches that a targeted NINJ1 molecule can inhibit lipid membrane rupture or breakage of a dead fate cell after an inflammasome is activated in a gout process and prevent release of cell contents, therefore, excessive inflammatory response caused by related DAMP can be inhibited, severe inflammation is controlled, and gout attack is relieved. The research finds that gout attack in an animal model can be remarkably relieved by using the NINJ1 specific neutralizing antibody for treatment, so that the targeted NINJ1 can be used for clinical treatment of gout.

Description

technical field [0001] The invention relates to the technical field of biomedicine and molecular targets, in particular to the use and pharmaceutical preparation of an anti-NINJ1 antibody in the preparation of a drug for treating gout. Background technique [0002] Gout is an inflammatory disease caused by the deposition of urate crystals in soft tissues such as joints and non-joints. Its clinical manifestations are extreme pain involving the joints of the lower extremities. Factors such as genetics and metabolism can lead to the accumulation of higher concentrations of uric acid in the blood. Under the stimulation of some physiological changes and external conditions, high concentrations of uric acid precipitate urate crystals and deposit in related tissues. Deposited urate can cooperate with other factors to activate NLRP3 inflammasome, produce active pro-inflammatory cytokine IL-1β, etc. to initiate gout inflammation, and the activation of NLRP3 inflammasome will further ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K39/395A61P19/06
CPCA61K39/3955A61P19/06
Inventor 陶金辉张宏亮高洁
Owner ANHUI PROVINCIAL HOSPITAL
Features
  • R&D
  • Intellectual Property
  • Life Sciences
  • Materials
  • Tech Scout
Why Patsnap Eureka
  • Unparalleled Data Quality
  • Higher Quality Content
  • 60% Fewer Hallucinations
Social media
Patsnap Eureka Blog
Learn More